Janoshik 99%+Semax
Peptide studied for BDNF and neuroplasticity signaling.
Discount applies to the quantity of this product in your cart.
Mechanism of action — research context
Semax is studied for enhancing BDNF (brain-derived neurotrophic factor), critical in research on learning, memory, and neuroplasticity. Investigation includes cerebral blood-flow and neuronal-signaling pathways, and cognitive markers examined without stimulant activity.
Frequently asked questions
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment, modified with an added tripeptide sequence so its neurotrophic and monoamine-pathway activity persists longer, while the corticotropic (hormonal) action of full ACTH is removed.
It's studied for BDNF/NGF expression, monoamine-pathway signaling in attention and cognition research, and neuroprotection in ischemia-model studies — its defining feature is the absence of ACTH's hormonal activity.
Each batch is analyzed by RP-HPLC and mass spectrometry for purity and sequence confirmation, with results published on an independent, batch-specific certificate of analysis.
As a lyophilized powder, keep it refrigerated prior to reconstitution; once reconstituted for laboratory use, store refrigerated and use within the compound's stability window.